Victory Capital Management
CRBP icon

Victory Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Victory Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,190
Closed -$285K – 2488
2024
Q4 		$285K Sell
24,190
-570
-2% -$9.56K ﹤0.01% 2154
2024
Q3 		$511K Buy
24,760
+5,700
+30% +$292K ﹤0.01% 1999
2024
Q2 		$862K Buy
+19,060
New +$802K ﹤0.01% 1771

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Victory Capital Management's CRBP Position: Q1 2025 in Review

Victory Capital Management sold out of Corbus Pharmaceuticals (CRBP) in Q1 2025, closing a stake of 24,190 shares — an estimated $285K sold.

Victory Capital Management first reported a position in CRBP in Q2 2024 and held it in 3 quarters. The position peaked at $862K in Q2 2024. 86 funds tracked by Wall St. Rank hold CRBP as of Q1 2025.

  • Victory Capital Management reported no remaining Corbus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Victory Capital Management sold 24,190 Corbus Pharmaceuticals shares in Q1 2025, an estimated $285K.
  • Victory Capital Management first reported a position in Corbus Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Victory Capital Management's Corbus Pharmaceuticals position peaked at $862K in Q2 2024.
  • 86 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2025.

Based on Victory Capital Management's 13F filing for Q1 2025, filed 2 May 2025.